Active Motif Europe
SARS-CoV-2 Spike Antibody (AM009105)
These fully human recombinant antibodies are derived from patients that were infected with SARS-CoV-2. They are specific for the SARS-CoV-2 Spike S1 protein and are suitable for use in various applications, including ELISAs, immunoblots, and neutralization assays.
All 9 recombinant antibodies are now available for research or commercial purposes.